Delving into the Latest Updates on Tianjin Zhongxin Pharmaceutical Group Corporation Limited with Synapse

Overview

Tags

Endocrinology and Metabolic Disease

Cardiovascular Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Small molecule drug	2

Top 5 Target	Count

P2Y12 receptor(Purinergic receptor P2Y12)	1
SUR(Sulfonylurea receptor)	1

评价天津中新药业集团股份有限公司新新制药厂的盐酸硫必利片（规格：100mg/片（按硫必利计））与持证商为Sanofi S.p.A.的盐酸硫必利片（规格：100mg/片（按硫必利计），商品名：SEREPRILE，赛诺菲生产）在健康成年受试者餐后状态下单次口服给药的人体生物等效性。

[Translation]

To evaluate the bioequivalence of sulpride hydrochloride tablets (specification: 100 mg/tablet (calculated as sulpride)) produced by Xinxin Pharmaceutical Factory of Tianjin Zhongxin Pharmaceutical Group Co., Ltd. and sulpride hydrochloride tablets (specification: 100 mg/tablet (calculated as sulpride), trade name: SEREPRILE, produced by Sanofi) produced by the licensee Sanofi S.p.A. after single oral administration in healthy adult subjects in the fed state.

Start Date07 Jul 2020

Sponsor / Collaborator

Tianjin Zhongxin Pharmaceutical Group Corporation Limited

CTR20191307 / Completed

盐酸硫必利片在中国健康受试者空腹和餐后状态下单中心、随机、开放、双周期、双交叉设计的生物等效性试验

[Translation] A single-center, randomized, open-label, two-period, double-crossover bioequivalence study of tiapride hydrochloride tablets in Chinese healthy volunteers under fasting and fed conditions

主要目的：评价天津中新药业集团股份有限公司新新制药厂的盐酸硫必利片（规格：100mg/片（按硫必利计））与持证商为Sanofi S.p.A.的盐酸硫必利片（规格：100mg/片（按硫必利计），商品名：SEREPRILE®，赛诺菲生产）在健康成年受试者空腹和餐后状态下单次口服给药的人体生物等效性。次要目的：评价盐酸硫必利片在健康成年受试者中的安全性。

[Translation]

Primary objective: To evaluate the bioequivalence of single oral administration of sulpride hydrochloride tablets (specification: 100 mg/tablet (calculated as sulpride)) produced by Xinxin Pharmaceutical Factory of Tianjin Zhongxin Pharmaceutical Group Co., Ltd. and sulpride hydrochloride tablets (specification: 100 mg/tablet (calculated as sulpride), trade name: SEREPRILE®, produced by Sanofi) produced by the licensee Sanofi S.p.A. in healthy adult subjects under fasting and fed conditions. Secondary objective: To evaluate the safety of sulpride hydrochloride tablets in healthy adult subjects.

Start Date06 Jul 2019

Sponsor / Collaborator

Tianjin Zhongxin Pharmaceutical Group Corporation Limited

CTR20181542 / Completed

盐酸二甲双胍片在中国健康成年受试者中随机开放两制剂单次给药双周期双交叉空腹和餐后状态下生物等效性试验

[Translation] A randomized, open-label, double-period, double-crossover bioequivalence study of two single-dose metformin hydrochloride tablets in healthy Chinese adult subjects under fasting and fed conditions

以天津中新药业集团股份有限公司新新制药厂提供的盐酸二甲双胍片为受试制剂，按生物等效性试验的有关规定，与日本新药株式会社生产的盐酸二甲双胍片(商品名：Glycoran®，参比制剂）对比在中国健康成年人体内的吸收速度及吸收程度，考察两制剂的人体生物等效性。

[Translation]

Metformin hydrochloride tablets provided by Xinxin Pharmaceutical Factory of Tianjin Sino-Singapore Pharmaceutical Group Co., Ltd. were used as the test preparation. According to the relevant provisions of the bioequivalence test, the absorption rate and degree of metformin hydrochloride tablets (trade name: Glycoran®, reference preparation) produced by Nippon Shinyaku Co., Ltd. were compared in healthy Chinese adults to investigate the bioequivalence of the two preparations in humans.

Start Date30 Sep 2018

Sponsor / Collaborator

Tianjin Zhongxin Pharmaceutical Group Corporation Limited

100 Clinical Results associated with Tianjin Zhongxin Pharmaceutical Group Corporation Limited

Login to view more data

0 Patents (Medical) associated with Tianjin Zhongxin Pharmaceutical Group Corporation Limited

Login to view more data

100 Deals associated with Tianjin Zhongxin Pharmaceutical Group Corporation Limited

Login to view more data

100 Translational Medicine associated with Tianjin Zhongxin Pharmaceutical Group Corporation Limited

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

2

Login to view more data